Advanced Filter

Filter by Group

Filter by Market Availability

Did you mean 10 205 3?
Displaying drugs 8551 - 8575 of 10017 in total
Distigmine is a parasympathomimetic agent with a longer duration of action and enhanced drug accumulation compared to DB00545 and DB01400. It is an anticholinergic drug and long-acting reversible carbamate cholinesterase inhibitor that binds directly and competitively to the agonist binding sites of muscurinic receptors. Distigmine is available in several countries...
Experimental
Matched Iupac: … 1-methyl-3-{[methyl({6-[methyl({[(1-methylpyridin-1-ium-3-yl)oxy]carbonyl})amino]hexyl})carbamoyl]oxy …
Retagliptin is under investigation in clinical trial NCT02822534 (The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patients).
Investigational
Matched Iupac: … methyl 7-[(3R)-3-amino-4-(2,4,5-trifluorophenyl)butanoyl]-3-(trifluoromethyl)-5H,6H,7H,8H-imidazo[1,5 …
V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)).
Investigational
Matched Iupac: … 3-chloro-5-[(1S)-1,2-dihydroxyethyl]-N-[5-(trifluoromethyl)pyridin-2-yl]-1',2',3',6'-tetrahydro-[2,4' …
Volixibat, also known as SHP626 or LUM002, is an investigational drug that will potentially be used for the treatment of Non-Alcoholic Steatohepatitis (NASH). If approved for use, it will be the first available agent for the treatment of NASH. Volixibat is a selective inhibitor of the apical sodium-dependent bile acid...
Experimental
Investigational
Matched Iupac: … {[(2R,3R,4S,5R,6R)-4-(benzyloxy)-6-[({3-[(3S,4R,5R)-3-butyl-7-(dimethylamino)-3-ethyl-4-hydroxy-1,1-dioxo …
Investigational
Matched Iupac: … (2S)-5-carbamimidamido-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-2-[(2S,3R)-3-hydroxy-2-{[(2S)-1-[(2S)-pyrrolidine ... -2-carbonyl]pyrrolidin-2-yl]formamido}butanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}butanamido …
PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Investigational
Matched Iupac: … N-[(1S)-1-(3-fluorophenyl)-3-[(1R,3S,5S)-3-[2-methyl-5-(2-methylpropanoyl)-1H,4H,5H,6H,7H-imidazo[4,5 …
Experimental
Illicit
Matched Iupac: … 4,4-diphenyl-6-(piperidin-1-yl)heptan-3-one …
A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]
Experimental
Illicit
Matched Iupac: … (3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl acetate …
Experimental
Matched Iupac: … (2S)-2-amino-3-(naphthalen-2-yl)propanoic acid …
Experimental
Matched Iupac: … (2E)-3-[4-(dihydroxyboranyl)phenyl]prop-2-enoic acid …
Experimental
Matched Iupac: … (2S,3S)-2-amino-3-hydroxy-4-methylpentanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-[(2-oxopropyl)sulfanyl]propanoic acid …
Experimental
Matched Iupac: … [(2R,3R)-2,3-dihydroxy-3-(hydroxycarbamoyl)propoxy]phosphonic acid …
Methaqualone is a sedative-hypnotic drug that is similar in effect to barbiturates, a general central nervous system depressant. The sedative-hypnotic activity was first noted by Indian researchers in the 1950s and in 1962 methaqualone itself was patented in the US by Wallace and Tiernan. Its use peaked in the early...
Illicit
Withdrawn
Matched Iupac: … 2-methyl-3-(2-methylphenyl)-3,4-dihydroquinazolin-4-one …
VNP40101M is a novel alkylating agent that has been used in trials studying the treatment of Leukemia, Lymphoma, Lung Cancer, Small Intestine Cancer, and Myelodysplastic Syndromes, among others.
Investigational
Matched Iupac: … 1-[N-(2-chloroethyl)methanesulfonamido]-1-methanesulfonyl-3-methylurea …
Bucillamine has been used in trials studying the treatment and prevention of Gout and Rheumatoid Arthritis.
Investigational
Matched Iupac: … (2R)-2-(2-methyl-2-sulfanylpropanamido)-3-sulfanylpropanoic acid …
AZD6280 has been used in trials studying the basic science of Anxiety.
Investigational
Matched Iupac: … 4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide …
Experimental
Matched Iupac: … (3R)-3-(6-methoxynaphthalen-2-yl)-2,2-dimethylpentanoic acid …
Experimental
Matched Iupac: … 4-(propan-2-yl)-2-[3-(trifluoromethyl)phenyl]morpholine …
Experimental
Matched Iupac: … 3-methylbutyl 2-{[2-(diethylamino)ethyl]amino}-2-phenylacetate …
Experimental
Matched Iupac: … N-{3-[1-hydroxy-2-(methylamino)ethyl]phenyl}methanesulfonamide …
Investigational
Matched Iupac: … (2S)-2-amino-3-[4-(¹³¹I)iodophenyl]propanoic acid …
Experimental
Matched Iupac: … -2-yl]-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxoimidazolidin-1-yl}butanamide ... (2S)-N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-[(E)-(hydroxyimino)methyl]benzenesulfonamido]-1-phenylbutan …
C-peptide is under investigation in clinical trial NCT00278980 (Effect of C-peptide on Diabetic Peripheral Neuropathy).
Investigational
Matched Iupac: … }-3-methylbutyl]carbamoyl}-2-hydroxyethyl]carbamoyl}methyl)carbamoyl]-3-carboxypropyl]carbamoyl}-3-methylbutyl ... ]carbamoyl}ethyl]carbamoyl}-3-methylbutyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}-3-methylbutyl ... [(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]propanamido]-4-carboxybutanamido]-3- ... ]-3-methylbutanamido]-4-{[(1S)-1-[({[({2-[(2S)-2-[({[(1S)-1-[({[(1S)-1-{[(1S)-1-{[(2S)-4-carbamoyl-1- ... carbamoyl}methyl)carbamoyl]pyrrolidin-1-yl]-2-oxoethyl}carbamoyl)methyl]carbamoyl}methyl)carbamoyl]-3- …
Experimental
Matched Iupac: … (2S)-2-amino-3-{[(2S,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}propanoic …
Displaying drugs 8551 - 8575 of 10017 in total